Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Neoplasms"" wg kryterium: Temat


Tytuł:
SLC27A4-mediated selective uptake of mono-unsaturated fatty acids promotes ferroptosis defense in hepatocellular carcinoma.
Autorzy:
Li Z; Key Laboratory of Liver Disease of Guangdong Province, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China; Department of Biochemistry Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
Liao X; Key Laboratory of Liver Disease of Guangdong Province, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China; Department of Biochemistry Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
Hu Y; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Li M; Key Laboratory of Liver Disease of Guangdong Province, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China; Department of Biochemistry Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
Tang M; Department of Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Zhang S; Department of Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Mo S; Key Laboratory of Liver Disease of Guangdong Province, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China; Department of Biochemistry Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
Li X; Key Laboratory of Liver Disease of Guangdong Province, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China; Department of Biochemistry Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
Chen S; Key Laboratory of Liver Disease of Guangdong Province, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China; Department of Biochemistry Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
Qian W; Key Laboratory of Liver Disease of Guangdong Province, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China; Department of Biochemistry Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
Feng R; Key Laboratory of Liver Disease of Guangdong Province, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China; Department of Biochemistry Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
Yu R; Molecular Diagnosis and Gene Testing Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Xu Y; Molecular Diagnosis and Gene Testing Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yuan S; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
Xie C; Key Laboratory of Liver Disease of Guangdong Province, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China. Electronic address: .
Li J; Key Laboratory of Liver Disease of Guangdong Province, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China; Department of Biochemistry Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China. Electronic address: .
Pokaż więcej
Źródło:
Free radical biology & medicine [Free Radic Biol Med] 2023 May 20; Vol. 201, pp. 41-54. Date of Electronic Publication: 2023 Mar 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/metabolism
Fatty Acid Transport Proteins*/metabolism
Ferroptosis*/genetics
Liver Neoplasms*/drug therapy
Liver Neoplasms*/genetics
Liver Neoplasms*/metabolism
Female ; Humans ; Breast Neoplasms ; Fatty Acids/metabolism ; Fatty Acids, Unsaturated ; Neoplasm Recurrence, Local ; Ovarian Neoplasms ; Sorafenib/pharmacology ; Sorafenib/therapeutic use ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Understanding the role of access in Hispanic cancer screening disparities.
Autorzy:
Spencer JC; Department of Population Health, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.; Department of Internal Medicine, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.; Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.
Noel L; Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.; Steve Hicks School of Social Work, University of Texas at Austin, Austin, Texas, USA.
Shokar NK; Department of Population Health, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.; Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.
Pignone MP; Department of Internal Medicine, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.; Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.
Pokaż więcej
Źródło:
Cancer [Cancer] 2023 May 15; Vol. 129 (10), pp. 1569-1578. Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Early Detection of Cancer*/economics
Early Detection of Cancer*/statistics & numerical data
Health Services Accessibility*/economics
Health Services Accessibility*/statistics & numerical data
Healthcare Disparities*/economics
Healthcare Disparities*/ethnology
Healthcare Disparities*/statistics & numerical data
Hispanic or Latino*/statistics & numerical data
Neoplasms*/diagnosis
Neoplasms*/economics
Neoplasms*/epidemiology
Neoplasms*/ethnology
White*/statistics & numerical data
Female ; Humans ; Breast Neoplasms/diagnosis ; Breast Neoplasms/economics ; Breast Neoplasms/epidemiology ; Breast Neoplasms/ethnology ; Colorectal Neoplasms/diagnosis ; Colorectal Neoplasms/economics ; Colorectal Neoplasms/epidemiology ; Colorectal Neoplasms/ethnology ; Insurance Coverage/economics ; Insurance Coverage/statistics & numerical data ; Mass Screening/economics ; Mass Screening/statistics & numerical data ; United States/epidemiology ; Uterine Cervical Neoplasms/diagnosis ; Uterine Cervical Neoplasms/economics ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/ethnology
Czasopismo naukowe
Tytuł:
Association between major discrimination and deficit accumulation in African American cancer survivors: The Detroit Research on Cancer Survivors Study.
Autorzy:
Mandelblatt JS; Department of Oncology, Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.; Georgetown Lombardi Institute for Cancer and Aging Research, Georgetown University, Washington, District of Columbia, USA.
Ruterbusch JJ; Department of Oncology, Wayne State University, Detroit, Michigan, USA.; Karmanos Cancer Institute, Detroit, Michigan, USA.
Thompson HS; Department of Oncology, Wayne State University, Detroit, Michigan, USA.; Karmanos Cancer Institute, Detroit, Michigan, USA.
Zhou X; Department of Oncology, Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.; Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.; Office of Minority Health and Health Disparities Research, Georgetown University, Washington, District of Columbia, USA.
Bethea TN; Department of Oncology, Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.
Adams-Campbell L; Department of Oncology, Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA.
Purrington K; Department of Oncology, Wayne State University, Detroit, Michigan, USA.; Karmanos Cancer Institute, Detroit, Michigan, USA.
Schwartz AG; Department of Oncology, Wayne State University, Detroit, Michigan, USA.; Karmanos Cancer Institute, Detroit, Michigan, USA.
Pokaż więcej
Źródło:
Cancer [Cancer] 2023 May 15; Vol. 129 (10), pp. 1557-1568. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Aging*/ethnology
Aging*/physiology
Black or African American*/statistics & numerical data
Cancer Survivors*
Neoplasms*/epidemiology
Neoplasms*/ethnology
Neoplasms*/physiopathology
Racism*/ethnology
Racism*/statistics & numerical data
Social Determinants of Health*/ethnology
Social Determinants of Health*/statistics & numerical data
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Young Adult ; Breast Neoplasms/epidemiology ; Breast Neoplasms/ethnology ; Breast Neoplasms/physiopathology ; Surveys and Questionnaires ; Michigan/epidemiology
Czasopismo naukowe
Tytuł:
An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group.
Autorzy:
Shimada M; Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai, Japan.; Tohoku University Advanced Research Center for Innovations in Next-Generation Medicine, Sendai, Japan. .
Yoshihara K; Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Chuo, Japan.
Tanigawa T; Department of Gynecology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Nomura H; Department of Obstetrics and Gynecology, School of Medicine, Fujita Health University, Toyoake, Japan.
Hamanishi J; Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Fujiwara S; Department of Obstetrics and Gynecology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Tanabe H; Department of Gynecology, National Cancer Center Hospital East, Kashiwa, Japan.
Kajiyama H; Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Showa-ku, Japan.
Mandai M; Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Aoki D; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
Enomoto T; Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Chuo, Japan.
Okamoto A; Department of Obstetrics and Gynecology, Jikei University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Journal of gynecologic oncology [J Gynecol Oncol] 2023 May; Vol. 34 (3), pp. e62. Date of Electronic Publication: 2023 Apr 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Ovarian Epithelial*/drug therapy
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/pathology
Poly(ADP-ribose) Polymerase Inhibitors*/adverse effects
Poly(ADP-ribose) Polymerase Inhibitors*/therapeutic use
Female ; Humans ; East Asian People ; Genital Neoplasms, Female/drug therapy ; Genital Neoplasms, Female/therapy ; Genome-Wide Association Study ; Poly(ADP-ribose) Polymerases/therapeutic use
Czasopismo naukowe
Tytuł:
PI3Kβ controls immune evasion in PTEN-deficient breast tumours.
Autorzy:
Bergholz JS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Wang Q; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Wang Q; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Geode Therapeutics, Inc., Boston, MA, USA.
Ramseier M; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Institute for Medical Engineering and Science (IMES), Department of Chemistry, and Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Prakadan S; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Institute for Medical Engineering and Science (IMES), Department of Chemistry, and Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Wang W; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Fang R; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ningbo Clinical Pathology Diagnosis Center, Ningbo, P. R. China.
Kabraji S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.
Zhou Q; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.
Gray GK; Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.
Abell-Hart K; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Xie S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Guo X; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Gu H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Von T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Jiang T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Tang S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.
Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Kim HJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Immunology Discovery, Genentech, South San Francisco, CA, USA.
Shalek AK; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Institute for Medical Engineering and Science (IMES), Department of Chemistry, and Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Roberts TM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. thomas_.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. thomas_.
Zhao JJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. jean_.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. jean_.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. jean_.
Pokaż więcej
Źródło:
Nature [Nature] 2023 May; Vol. 617 (7959), pp. 139-146. Date of Electronic Publication: 2023 Apr 19.
Typ publikacji:
Journal Article
MeSH Terms:
Immune Evasion*
Phosphatidylinositol 3-Kinase*/metabolism
PTEN Phosphohydrolase*/deficiency
PTEN Phosphohydrolase*/genetics
Mammary Neoplasms, Animal*/enzymology
Mammary Neoplasms, Animal*/genetics
Mammary Neoplasms, Animal*/immunology
Animals ; Mice ; Immunotherapy ; Phosphoinositide-3 Kinase Inhibitors ; Signal Transduction ; Mammary Neoplasms, Experimental/enzymology ; Mammary Neoplasms, Experimental/genetics ; Mammary Neoplasms, Experimental/immunology
Czasopismo naukowe
Tytuł:
Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost.
Autorzy:
Embring A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. .; Department of Oncology, Karolinska University Hospital, Anna Steckséns Gata 41, 171 76, Solna, Stockholm, Sweden. .
Onjukka E; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.
Mercke C; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Karolinska University Hospital, Anna Steckséns Gata 41, 171 76, Solna, Stockholm, Sweden.
Lax I; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.
Berglund A; Epistat Epidemiology and Statistics Consulting, Uppsala, Sweden.
Friesland S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Karolinska University Hospital, Anna Steckséns Gata 41, 171 76, Solna, Stockholm, Sweden.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Apr 07; Vol. 18 (1), pp. 65. Date of Electronic Publication: 2023 Apr 07.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Brachytherapy*/adverse effects
Oropharyngeal Neoplasms*/pathology
Oropharyngeal Neoplasms*/radiotherapy
Radiotherapy Dosage*
Squamous Cell Carcinoma of Head and Neck*/pathology
Squamous Cell Carcinoma of Head and Neck*/radiotherapy
Humans ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/radiotherapy ; Neoplasm Recurrence, Local/prevention & control ; Neoplasm Staging ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer.
Autorzy:
Cho MS; The Division of Colon and Rectal Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Bae HW; The Division of Colon and Rectal Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Chang JS; Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea.
Yang SY; The Division of Colon and Rectal Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Kim TH; Graduate School of Public Health, Yonsei University, Seoul, Korea.
Koom WS; Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea.
Shin SJ; The Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Choi GS; The Division of Colon and Rectal Surgery, Department of Surgery, Kyungpook National University Medical Center, Daegu, Korea.
Kim NK; The Division of Colon and Rectal Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło:
Yonsei medical journal [Yonsei Med J] 2023 Jun; Vol. 64 (6), pp. 395-403.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Chemoradiotherapy*/methods
Rectal Neoplasms*/drug therapy
Rectal Neoplasms*/pathology
Rectal Neoplasms*/radiotherapy
Rectal Neoplasms*/surgery
Radiotherapy*/methods
Humans ; Asian People ; Capecitabine/therapeutic use ; Cost-Benefit Analysis ; Neoplasms, Second Primary ; Proctectomy/methods
Czasopismo naukowe
Tytuł:
BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil.
Autorzy:
Mazzonetto P; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Milanezi F; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
D'Andrea M; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Martins S; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Monfredini PM; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Dos Santos Silva J; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Perrone E; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Villela D; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Schnabel B; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Nakano V; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Palmero EI; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Braggio E; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Cavalcanti TL; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Guida G; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Migliavacca MP; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Scapulatempo-Neto C; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil.
Zalcberg I; Diagnósticos da América S.A., DASA, Av. Divino Salvador, 876 3Rd Floor, Zip Code, São Paulo-SP, 04078-013, Brazil. .
Pokaż więcej
Źródło:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 May; Vol. 199 (1), pp. 127-136. Date of Electronic Publication: 2023 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
BRCA1 Protein*/genetics
BRCA2 Protein*/genetics
Breast Neoplasms*/epidemiology
Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Adult ; Female ; Humans ; Brazil/epidemiology ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Mutation ; Ovarian Neoplasms/genetics
Czasopismo naukowe
Tytuł:
Role of UCP2 in the Energy Metabolism of the Cancer Cell Line A549.
Autorzy:
Segalés J; Centro de Investigaciones Biológicas Margarita Salas, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.
Sánchez-Martín C; Centro de Investigaciones Biológicas Margarita Salas, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.
Pujol-Morcillo A; Centro de Investigaciones Biológicas Margarita Salas, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.
Martín-Ruiz M; Centro de Investigaciones Biológicas Margarita Salas, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.
de Los Santos P; Centro de Investigaciones Biológicas Margarita Salas, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.
Lobato-Alonso D; Centro de Investigaciones Biológicas Margarita Salas, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.
Oliver E; Centro de Investigaciones Biológicas Margarita Salas, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.
Rial E; Centro de Investigaciones Biológicas Margarita Salas, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 01; Vol. 24 (9). Date of Electronic Publication: 2023 May 01.
Typ publikacji:
Journal Article
MeSH Terms:
Energy Metabolism*
Ion Channels*/genetics
Ion Channels*/metabolism
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Uncoupling Protein 2*/genetics
Uncoupling Protein 2*/metabolism
Humans ; Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/metabolism ; Adenosine Triphosphate/metabolism ; Cell Line ; Mitochondrial Proteins/genetics ; Mitochondrial Proteins/metabolism ; Mitochondrial Uncoupling Proteins/metabolism ; Neoplasms ; Reactive Oxygen Species/metabolism
Czasopismo naukowe
Tytuł:
Cancer Distribution Among Asian, Native Hawaiian, and Pacific Islander Subgroups - United States, 2015-2019.
Autorzy:
Bock S; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC.
Henley SJ; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC.
O'Neil ME; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC.
Singh SD; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC.
Thompson TD; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC.
Wu M; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, CDC.
Pokaż więcej
Źródło:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2023 Apr 21; Vol. 72 (16), pp. 421-425. Date of Electronic Publication: 2023 Apr 21.
Typ publikacji:
Journal Article
MeSH Terms:
Asian*/statistics & numerical data
Native Hawaiian or Other Pacific Islander*/statistics & numerical data
Pacific Island People*/statistics & numerical data
Neoplasms*/epidemiology
Neoplasms*/ethnology
Neoplasms*/pathology
Health Status Disparities*
Female ; Humans ; Breast Neoplasms/epidemiology ; United States/epidemiology ; Centers for Disease Control and Prevention, U.S./statistics & numerical data ; Social Determinants of Health/ethnology ; Social Determinants of Health/statistics & numerical data ; Culturally Competent Care/ethnology
Czasopismo naukowe
Tytuł:
"There's not enough studies": Views of black breast and ovarian cancer patients on research participation.
Autorzy:
Riggan KA; Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota, USA.
Rousseau A; Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota, USA.
Halyard M; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA.; Coalition of Blacks Against Breast Cancer, Phoenix, Arizona, USA.; ADVANCE Community Advisory Board, Phoenix, Arizona, USA.
James SE; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA.; Coalition of Blacks Against Breast Cancer, Phoenix, Arizona, USA.
Kelly M; Coalition of Blacks Against Breast Cancer, Phoenix, Arizona, USA.; ADVANCE Community Advisory Board, Phoenix, Arizona, USA.; Department of Community Engagement, Mayo Clinic, Scottsdale, Arizona, USA.
Phillips D; ADVANCE Community Advisory Board, Phoenix, Arizona, USA.; Department of Speech Pathology, Mayo Clinic, Phoenix, Arizona, USA.
Allyse MA; Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota, USA.; Department of Obstetrics & Gynecology, Mayo Clinic, Rochester, Minnesota, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 8767-8776. Date of Electronic Publication: 2023 Jan 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Ovarian Neoplasms*/epidemiology
Ovarian Neoplasms*/therapy
Trust*
Female ; Humans ; Black or African American ; Qualitative Research ; Breast Neoplasms ; Clinical Trials as Topic/psychology ; Research Subjects/psychology ; Patient Participation/psychology
Czasopismo naukowe
Tytuł:
The Discovery and Anti-Colorectal Cancer Activities of Cembranolides from the South China Sea Soft Coral Sinularia pendunculata.
Autorzy:
Wang HR; Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Jin Y; Natural Products Chemistry Department, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, 264117, China.
Sun RN; Natural Products Chemistry Department, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, 264117, China.
Yao LG; Natural Products Chemistry Department, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
Xia JH; Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Huang Y; Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Liu SH; Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Zhang WD; Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.; Department of Phytochemistry, School of Pharmacy, Second Military Medical University, Shanghai, 200433, China.
Li XW; Natural Products Chemistry Department, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, 264117, China.
Pokaż więcej
Źródło:
Chemistry & biodiversity [Chem Biodivers] 2023 Apr; Vol. 20 (4), pp. e202300214. Date of Electronic Publication: 2023 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
Anthozoa*/chemistry
Diterpenes*/pharmacology
Diterpenes*/chemistry
Neoplasms*
Antineoplastic Agents*/chemistry
Antineoplastic Agents*/pharmacology
Animals ; China ; Molecular Structure ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/prevention & control
Czasopismo naukowe
Tytuł:
Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4.
Autorzy:
Ghiaur G; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
Valkenburg KC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
Esteb C; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
Ambinder A; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
Imus PH; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
Pienta KJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
Jones RJ; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Cancer [Cancer] 2023 Jun 01; Vol. 129 (11), pp. 1744-1751. Date of Electronic Publication: 2023 Feb 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Cytochrome P-450 CYP3A*/genetics
Cytochrome P-450 CYP3A*/metabolism
Neoplasms, Second Primary*/pathology
Humans ; Bone Marrow/pathology ; Bone Marrow Cells/metabolism ; Cell Line, Tumor ; Cytochrome P-450 Enzyme System/metabolism ; Tumor Microenvironment ; Neoplasms/pathology
Czasopismo naukowe
Tytuł:
Mycoplasma infection mimicking a malignancy in a waldenstrom macroglobulinemia patient.
Autorzy:
Wu J; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China.
He D; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China.
Yu F; Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.
Huang Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.
Bian M; Department of Hematology, The Second People's Hospital of Huai'an, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huaian, 223001, China.
Yu C; Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, Ministry of Education, Zhejiang University School of Medicine, Hangzhou, 310000, Zhejiang, China.
Liu J; Hangzhou Xixi Hospital, Zhejiang University of Traditional Chinese Medicine, Hangzhou, 310000, Zhejiang, China.
Cai Z; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China.; Institute of Hematology, Zhejiang University, Hangzhou, 310000, Zhejiang, China.; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, 310000, China.
Zhao Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China. .; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Apr 07; Vol. 23 (1), pp. 219. Date of Electronic Publication: 2023 Apr 07.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*
Waldenstrom Macroglobulinemia*/diagnosis
Humans ; Fluorodeoxyglucose F18 ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography ; Radiopharmaceuticals ; Diagnosis, Differential ; Neoplasms
Czasopismo naukowe
Tytuł:
Potential impact of ADAM-10 genetic variants with the clinical features of oral squamous cell carcinoma.
Autorzy:
Chen YT; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Lin CW; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Chou YE; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.
Su SC; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan.; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan.
Chang LC; Department of Mathematical Sciences, Florida Atlantic University, Boca Raton, Florida, USA.
Lee CY; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Nobel Eye Institute, Taipei, Taiwan.
Hsieh MJ; Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Yang SF; Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Pokaż więcej
Źródło:
Journal of cellular and molecular medicine [J Cell Mol Med] 2023 Apr; Vol. 27 (8), pp. 1144-1152. Date of Electronic Publication: 2023 Mar 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
ADAM10 Protein*/genetics
Carcinoma, Squamous Cell*/genetics
Mouth Neoplasms*/genetics
Humans ; Male ; Case-Control Studies ; Genetic Predisposition to Disease ; Head and Neck Neoplasms ; Polymorphism, Single Nucleotide/genetics ; Risk Factors ; Squamous Cell Carcinoma of Head and Neck
Czasopismo naukowe
Tytuł:
Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy.
Autorzy:
Yang Q; Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China.; Nursing Department, The Third Xiangya Hospital, Central South University, Changsha, China.
Zeng S; Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
Liu W; Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China.
Pokaż więcej
Źródło:
PeerJ [PeerJ] 2023 Mar 17; Vol. 11, pp. e15019. Date of Electronic Publication: 2023 Mar 17 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Apoptosis*
Dihydrolipoyllysine-Residue Acetyltransferase*/genetics
Neoplasms*/enzymology
Neoplasms*/genetics
Humans ; Male ; Adenocarcinoma of Lung/genetics ; Autophagy ; Breast Neoplasms/genetics ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Non-Small-Cell Lung ; Carcinoma, Renal Cell/genetics ; Carcinoma, Squamous Cell/genetics ; Copper ; Kidney Neoplasms/genetics ; Liver Neoplasms/genetics ; Lung Neoplasms/genetics ; Stomach Neoplasms/genetics
Czasopismo naukowe
Tytuł:
Asparaginyl endopeptidase contributes to cetuximab resistance via MEK/ERK signaling in RAS wide-type metastatic colorectal cancer.
Autorzy:
Xu X; Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Liu M; Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Peng K; Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Yu Y; Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Liu T; Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. .; Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. .; Center of Evidence-Based Medicine, Fudan University, 180 Feng Lin Road, Shanghai, 200032, China. .
Pokaż więcej
Źródło:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Mar; Vol. 25 (3), pp. 776-785. Date of Electronic Publication: 2023 Jan 07.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Drug Resistance, Neoplasm*/genetics
Cysteine Endopeptidases*/genetics
Cysteine Endopeptidases*/metabolism
Humans ; Cetuximab/pharmacology ; Cetuximab/therapeutic use ; Colonic Neoplasms/drug therapy ; Colonic Neoplasms/genetics ; ErbB Receptors/genetics ; Mitogen-Activated Protein Kinase Kinases/metabolism ; Mutation ; Proto-Oncogene Proteins p21(ras)/genetics ; Rectal Neoplasms/drug therapy ; Rectal Neoplasms/genetics ; Signal Transduction ; MAP Kinase Signaling System
Czasopismo naukowe
Tytuł:
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.
Autorzy:
Clark NM; Department of Surgery, University of Washington, Seattle, USA.
Roberts EA; University of Washington School of Medicine, Seattle, USA.
Fedorenko C; Hutchinson Institute for Cancer Outcomes Research Fred Hutchinson Cancer Center, Seattle, USA.
Sun Q; Hutchinson Institute for Cancer Outcomes Research Fred Hutchinson Cancer Center, Seattle, USA.
Dubard-Gault M; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, USA.; Fred Hutchinson Cancer Center, Seattle, USA.
Handford C; Fred Hutchinson Cancer Center, Seattle, USA.
Yung R; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, USA.
Cheng HH; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, USA.
Sham JG; Department of Surgery, University of Washington, Seattle, USA.; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, USA.
Norquist BM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, USA.
Flanagan MR; Department of Surgery, University of Washington, Seattle, USA. .; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, USA. .
Pokaż więcej
Źródło:
Annals of surgical oncology [Ann Surg Oncol] 2023 Mar; Vol. 30 (3), pp. 1312-1326. Date of Electronic Publication: 2022 Nov 05.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/genetics
Genetic Testing*
Ovarian Neoplasms*/genetics
Prostatic Neoplasms*/genetics
Pancreatic Neoplasms*/genetics
Female ; Humans ; Male ; Genetic Counseling ; Pancreatic Hormones ; Retrospective Studies ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/pathology
Czasopismo naukowe
Tytuł:
Practice patterns for reporting digestive system neuroendocrine neoplasms: results from a large, comprehensive international survey.
Autorzy:
Karamchandani DM; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
Cox B; Department of Pathology, Cedars Sinai Health System, Los Angeles, CA, USA.
La Rosa S; Unit of Pathology, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Bellizzi AM; Department of Pathology, University of Iowa, Iowa City, IA, USA.
Shi C; Department of Pathology, Duke University, Durham, NC, USA.
Gonzalez RS; Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, GA, USA.
Pokaż więcej
Źródło:
Histopathology [Histopathology] 2023 Mar; Vol. 82 (4), pp. 541-554. Date of Electronic Publication: 2023 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Ki-67 Antigen*/analysis
Ki-67 Antigen*/genetics
Neuroendocrine Tumors*/genetics
Neuroendocrine Tumors*/metabolism
Neuroendocrine Tumors*/pathology
Digestive System Neoplasms*/genetics
Digestive System Neoplasms*/metabolism
Digestive System Neoplasms*/pathology
Humans ; Appendiceal Neoplasms/genetics ; Appendiceal Neoplasms/metabolism ; Appendiceal Neoplasms/pathology ; Intestinal Neoplasms/genetics ; Intestinal Neoplasms/metabolism ; Intestinal Neoplasms/pathology ; Neoplasm Grading ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/metabolism ; Pancreatic Neoplasms/pathology
Czasopismo naukowe
Tytuł:
Six case reports of NTHL1-associated tumor syndrome further support it as a multi-tumor predisposition syndrome.
Autorzy:
Weatherill CB; Hoag Family Cancer Institute, Newport Beach, California, USA.
Burke SA; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Haskins CG; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Berry DK; Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
Homer JP; Hoag Family Cancer Institute, Newport Beach, California, USA.
Demeure MJ; Hoag Family Cancer Institute, Newport Beach, California, USA.; Translational Genomics Research Institute, Phoenix, Arizona, USA.
Darabi S; Hoag Family Cancer Institute, Newport Beach, California, USA.
Pokaż więcej
Źródło:
Clinical genetics [Clin Genet] 2023 Feb; Vol. 103 (2), pp. 231-235. Date of Electronic Publication: 2022 Oct 17.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenomatous Polyposis Coli*/diagnosis
Adenomatous Polyposis Coli*/genetics
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/genetics
Deoxyribonuclease (Pyrimidine Dimer)*/genetics
Female ; Humans ; Genetic Predisposition to Disease ; Breast Neoplasms/genetics ; Meningioma/genetics ; Endometrial Neoplasms/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies